Tyrosine kinase inhibitors in sarcoma treatment

Autor: Kyriazoglou, Anastassios, Gkaralea, Lydia Evangeli, Kotsantis, Ioannis, Anastasiou, Maria, Pantazopoulos, Anastasios, Prevezanou, Maria, Chatzidakis, Ioannis, Kavourakis, Georgios, Economopoulou, Panagiota, Fragkandrea Nixon, Ioanna, Psyrri, Amanda

Publikováno v: National Library of Medicine

Sarcomas are a group of rare mesenchymal malignant tumors that arise from transformed cells of the mesenchymal connective tissue, which are challenging to treat. The majority of sarcomas are soft tissue sarcomas (STSs; 75%) and this heterogeneous gro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::03b56b8532a095138fc2bb61b60a2d62
https://strathprints.strath.ac.uk/80748/1/Kyriazoglou_NLM_2022_Tyrosine_kinase_inhibitors_in_sarcoma_treatment.pdf

Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions

Autor: Economopoulou, Panagiota Pantazopoulos, Anastasios Spathis, Aris and Kotsantis, Ioannis Kyriazoglou, Anastasios Kavourakis, George Zakopoulou, Roubini Chatzidakis, Ioannis Anastasiou, Maria Prevezanou, Maria Resteghini, Carlo Licitra, Lisa and Bergamini, Cristiana Colombo, Elena Caspani, Francesca and Denaro, Nerina Vecchio, Stefania Bonomo, Pierluigi Cossu Rocca, Maria Bertolini, Federica Ferrari, Daris Psyrri, Amanda Bossi, Paolo

Background: nasopharyngeal carcinoma (NPC) is a complex disease entity that mainly predominates in endemic regions. Real-world data with immunotherapy from nonendemic regions are limited. Methods: we collected data from patients with recurrent/metast

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::90b2371887a8f468c1a8495d999b3199
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3033880

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions.

Autor: Economopoulou P; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Pantazopoulos A; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Spathis A; Second Department of Pathology, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Kotsantis I; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Kyriazoglou A; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Kavourakis G; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Zakopoulou R; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Chatzidakis I; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Anastasiou M; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Prevezanou M; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Resteghini C; Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Licitra L; Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Bergamini C; Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Colombo E; Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Caspani F; Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milan, Italy., Denaro N; Medical Oncology Santa Croce and Carle General Hospital Cuneo, 12100 Cuneo, Italy., Vecchio S; IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy., Bonomo P; Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy., Cossu Rocca M; Department of Medical Oncology, Urogenital and Head and Neck Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy., Bertolini F; Medical Oncology Unit, Department of Oncology and Hematology, University Hospital of Modena, 41125 Modena, Italy., Ferrari D; Medical Oncology Unit, San Paolo Hospital, 20142 Milan, Italy., Psyrri A; Section of Medical Oncology, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Bossi P; Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, 25123 Brescia, Italy.

Publikováno v: Cells [Cells] 2021 Dec 23; Vol. 11 (1). Date of Electronic Publication: 2021 Dec 23.